Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$91.91 - $110.37 $16,635 - $19,976
-181 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$86.24 - $95.92 $4,312 - $4,796
50 Added 38.17%
181 $17,000
Q1 2021

May 11, 2021

BUY
$71.83 - $95.48 $6,321 - $8,402
88 Added 204.65%
131 $12,000
Q4 2020

Feb 08, 2021

BUY
$67.0 - $84.39 $871 - $1,097
13 Added 43.33%
43 $3,000
Q3 2020

Oct 30, 2020

BUY
$55.23 - $79.93 $717 - $1,039
13 Added 76.47%
30 $2,000
Q2 2020

Aug 04, 2020

SELL
$30.2 - $56.98 $282,309 - $532,649
-9,348 Reduced 99.82%
17 $1,000
Q2 2020

Jul 27, 2020

BUY
$30.2 - $56.98 $282,823 - $533,617
9,365 New
9,365 $1,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Jacobi Capital Management LLC Portfolio

Follow Jacobi Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jacobi Capital Management LLC with notifications on news.